These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 35993469)
1. Li R; Cui X; Sun W; Yang Z; Shen X; Zhu C Comb Chem High Throughput Screen; 2023; 26(7):1311-1323. PubMed ID: 35993469 [TBL] [Abstract][Full Text] [Related]
2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
3. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma. Zhang S; Xu L; Feng J; Tan D; Zhu Y; Hou J; Li W; Lv K; Wang W; Jiang L; Jiao M; Guo H Front Genet; 2022; 13():842351. PubMed ID: 35360875 [No Abstract] [Full Text] [Related]
4. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma. Ouyang X; Lv L; Zhao Y; Zhang F; Hu Q; Li Z; Zhu D; Li L Front Oncol; 2021; 11():801506. PubMed ID: 35087760 [TBL] [Abstract][Full Text] [Related]
5. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma. Qu LH; Fang Q; Yin T; Yi HM; Mei GB; Hong ZZ; Qiu XB; Zhou R; Dong HF Cancer Immunol Immunother; 2022 Oct; 71(10):2449-2467. PubMed ID: 35254477 [TBL] [Abstract][Full Text] [Related]
7. Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma. Zhan T; Gao X; Wang G; Li F; Shen J; Lu C; Xu L; Li Y; Zhang J Front Oncol; 2021; 11():626663. PubMed ID: 34336642 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238 [TBL] [Abstract][Full Text] [Related]
9. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. Peng H; Du X; Zhang Y Front Mol Biosci; 2022; 9():898567. PubMed ID: 35720121 [No Abstract] [Full Text] [Related]
10. Lu J; An SG; Ma JJ; Yang Y; Zhang L; Yu P; Tao H; Chen YF; Zhang HX Chin Med Sci J; 2022 Dec; 37(4):331-339. PubMed ID: 36647592 [TBL] [Abstract][Full Text] [Related]
11. Exploring the Prognostic Value, Immune Implication and Biological Function of Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X Front Immunol; 2021; 12():723293. PubMed ID: 34899687 [TBL] [Abstract][Full Text] [Related]
12. H2AFX might be a prognostic biomarker for hepatocellular carcinoma. Hu H; Zhong T; Jiang S Cancer Rep (Hoboken); 2023 Jan; 6(1):e1684. PubMed ID: 35903980 [TBL] [Abstract][Full Text] [Related]
13. The interaction between Zhang Z; Liu S Ann Med; 2023 Dec; 55(1):1111-1122. PubMed ID: 36947060 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma. Jiayu F; Jiang Y; Zhou X; Zhou M; Pan J; Ke Y; Zhen J; Huang D; Jiang W Aging (Albany NY); 2022 Dec; 14(23):9550-9578. PubMed ID: 36462500 [TBL] [Abstract][Full Text] [Related]
15. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma. Wang Z; Chen S; Wang G; Li S; Qin X Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380 [TBL] [Abstract][Full Text] [Related]
16. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma. Tian F; Cai D Gene; 2022 Jan; 807():145964. PubMed ID: 34530087 [TBL] [Abstract][Full Text] [Related]
17. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389 [TBL] [Abstract][Full Text] [Related]
18. SLC17A2 Expression Correlates with Prognosis and Immune Infiltrates in Hepatocellular Carcinoma. Wang Z; Chen X; Jiang Z Comb Chem High Throughput Screen; 2022; 25(12):2001-2015. PubMed ID: 35081886 [TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC). Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma. Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005 [No Abstract] [Full Text] [Related] [Next] [New Search]